› 4cia

X-ray diffraction
1.98Å resolution

Crystal structure of cathepsin A, complexed with compound 1

Released:
DOI: 10.2210/pdb4cia/pdb
PDB entry 4cia coloured by chain, front view.
PDB entry 4cia coloured by chain, side view.
PDB entry 4cia coloured by chain, top view.
Source organism: Homo sapiens
Primary publication:
Crystal structure of cathepsin A, a novel target for the treatment of cardiovascular diseases.
Schreuder HA, Liesum A, Kroll K, Böhnisch B, Buning C, Ruf S, Sadowski T
Biochem Biophys Res Commun 445 451-6 (2014)
PMID: 24530914

Function and Biology Details

Reaction catalysed: 
Release of a C-terminal amino acid with broad specificity.
Biochemical function:
Biological process:
Cellular component:
Sequence domains:

Structure analysis Details

Assembly composition:
homo dimer (preferred)
Assembly name:
PDBe Complex ID:
PDB-CPX-145363 (preferred)
Entry contents:
1 distinct polypeptide molecule
Macromolecule:
Lysosomal protective protein Chain: A
Molecule details ›
Chain: A
Length: 455 amino acids
Theoretical weight: 51.83 KDa
Source organism: Homo sapiens
Expression system: Spodoptera frugiperda
UniProt:
  • Canonical: P10619 (Residues: 29-480; Coverage: 100%)
Gene names: CTSA, PPGB
Sequence domains: Serine carboxypeptidase
Structure domains: alpha/beta hydrolase

Ligands and Environments

3 bound ligands:
Ligand 6KZ 1 x 6KZ
Ligand CD 7 x CD
Ligand NAG 2 x NAG
No modified residues

Experiments and Validation Details

Entry percentile scores
X-ray source: ESRF BEAMLINE ID14-4
Spacegroup: C2
Unit cell:
a: 90.106Å b: 101.295Å c: 48.077Å
α: 90° β: 101.91° γ: 90°
R-values:
R R work R free
0.173 0.17 0.232
Expression system: Spodoptera frugiperda

Quick links

Citations

1 review citation

Small molecule and peptide therapies for chronic heart failure: a patent review (2011 - 2014).
Raymer et al. (2015)
2 other articles

1 mention without citation

Tissue-Specific Proteomics Analysis of Anti-COVID-19 Nucleoside and Nucleotide Prodrug-Activating Enzymes Provides Insights into the Optimization of Prodrug Design and Pharmacotherapy Strategy.
Li et al. (2021)